Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
Titel:
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
Auteur:
Pernas, Sonia Gil-Gil, Miguel Olza, María Ochoa de Gumà, Anna Climent, Fina Petit, Anna Pla, María Jesús García-Tejedor, Amparo López-Ojeda, Ana Falo, Cati Fernandez-Otega, Adela Mesia, Carlos Pérez-Martin, Francisco Javier Urruticoechea, Ander Germà, Josep Ramon